Publications by authors named "Yulia Volchek"

Claim this Profile
O
Outcomes of Fedratinib in Routine Treatment of Ruxolitinib-Resistant or -Refractory Patients with Primary and Post-Polycythemia Vera or Essential Thrombocythemia Myelofibrosis: A Nationwide Retrospective Study.
Adrian Duek, Alexandra Tzinman, Kira Maziuk, Assaf Levy, Martin Ellis, Yulia Volchek

Acta Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia.
Jonathan Canaani, Meital Nagar, Gabriel Heering, Chen Gefen, Ronit Yerushalmi, Yulia Volchek

Oncotarget· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life Experience With Ponatinib in Chronic Myeloid Leukemia: A Multicenter Observational Study.
Adi Shacham-Abulafia, Pia Raanani, David Lavie, Yulia Volchek, Ron Ram

Clin Lymphoma Myeloma Leuk· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.
Nira Varda-Bloom, Ivetta Danylesko, Roni Shouval, Shiran Eldror, Atar Lev, Yulia Volchek

Oncotarget· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitive Replicate Real-Time Quantitative PCR of BCR-ABL Shows Deep Molecular Responses in Long-Term Post-Allogeneic Stem Cell Transplantation Chronic Myeloid Leukemia Patients.
Maya Koren-Michowitz, Avichai Shimoni, Filomena Daraio, Francesca Crasto, Roberta Lorenzatti, Yulia Volchek

Biol Blood Marrow Transplant· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation.
Maya Koren-Michowitz, Hannah Maayan, Arie Apel, Noga Shem-Tov, Ronit Yerushalmi, Yulia Volchek

Ann Hematol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.
Avichai Shimoni, Yulia Volchek, Maya Koren-Michowitz, Nira Varda-Bloom, Raz Somech

Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.
Abraham Avigdor, Tsvi Sirotkin, Meirav Kedmi, Elena Ribakovsy, Miriam Berkowicz, Yulia Volchek

Ann Hematol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nilotinib-associated acute pancreatitis.
Tal Engel, Dan Justo, Michal Amitai, Yulia Volchek, Haim Mayan

Ann Pharmacother· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib plasma trough levels in chronic myeloid leukaemia: results of a multicentre study CSTI571AIL11TGLIVEC.
Maya Koren-Michowitz, Yulia Volchek, Elizabeth Naparstek, Israel Gavish, Itai Levi

Hematol Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis